Archives of Physical Medicine and Rehabilitation
Volume 90, Issue 9 , Pages 1453-1461 , September 2009

A Preliminary Assessment of the Benefits of the Addition of Botulinum Toxin A to a Conventional Therapy Program on the Function of People With Longstanding Stroke

  • Jay M. Meythaler, MD, JD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Wayne State University School of Medicine, Rehabilitation Institute of Michigan, Detroit MI
    • Corresponding Author InformationCorrespondence to Jay M. Meythaler, MD, JD, Professor, Dept Physical Medicine and Rehabilitation, Wayne State University, School of Medicine, Rm 822 Rehabilitation Institute of Michigan, Detroit, MI 48201
  • ,
  • Laura Vogtle, PhD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, School of Medicine and the University of Alabama at Birmingham, Spain Rehabilitation Center, Birmingham, AL
  • ,
  • Robert C. Brunner, MD

      Affiliations

    • Department of Occupational Therapy, School of Health Professions, University of Alabama at Birmingham, Birmingham, AL

  • Image Result

    The CONSORT diagram.

    The CONSORT diagram.

  • Image Result

    The mean MAL with standard deviation bars or AOU presented individually for both group 1 BTX-A/drug followed by placebo and group 2 placebo followed by BTX-A at baseline and the end of each 12-week ar

    The mean MAL with standard deviation bars or AOU presented individually for both group 1 BTX-A/drug followed by placebo and group 2 placebo followed by BTX-A at baseline and the end of each 12-week arm.

  • Image Result
    The mean MAL with standard deviation bars for QOM presented individually for both group 1 BTX-A/drug followed by placebo and group 2 placebo followed by BTX-A at baseline and the end of each 12-week a

    The mean MAL with standard deviation bars for QOM presented individually for both group 1 BTX-A/drug followed by placebo and group 2 placebo followed by BTX-A at baseline and the end of each 12-week arm.

 Supported by an unrestricted grant to University of Alabama at Birmingham by Allergan Inc. Allergan was allowed to see a prior draft of this article and make comments, but the authors made all decisions regarding the final content.

 A commercial party having a direct financial interest in the results of the research supporting this article has not conferred nor will confer a financial benefit on the author or one or more of the authors.

 Reprints are not available from the author.

PII: S0003-9993(09)00357-8

doi: 10.1016/j.apmr.2009.02.026

Archives of Physical Medicine and Rehabilitation
Volume 90, Issue 9 , Pages 1453-1461 , September 2009